Atrial Fibrillation: Chronic Beta-blocker Use Versus As-needed Rate Control Guided by Implantable Cardiac Monitor
Conditions:   Atrial Fibrillation;   Diastolic Dysfunction;   HFpEF - Heart Failure With Preserved Ejection Fraction Intervention:   Drug: As needed pharmacological rate control with beta-blocker (metoprolol tartrate, metoprolol succinate) or calcium channel blocker (diltiazem, verapamil) Sponsor:   University of Vermont Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of Metoprolol Tartrate Tablets Combined With Chinese Traditional Medicine on Premature Ventricular Complex.
Condition:   Premature Ventricular Contraction Interventions:   Drug: Tongmai Yangxin Pill (TMYXP);   Drug: metoprolol tartrate;   Drug: placebo Sponsors:   Xuanwu Hospital, Beijing;   Tianjin Lerentang factory Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2021 Category: Research Source Type: clinical trials

Rate Control in Atrial Fibrillation: A Randomized, Double-Blind, Crossover Comparison of Carvedilol and Metoprolol Tartrate
Condition:   Atrial FibrillationInterventions:   Drug: Carvedilol;   Drug: Metoprolol tartrateSponsor:   Creighton UniversityNot yet recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2014 Category: Research Source Type: clinical trials

Rate Control in Atrial Fibrillation: A Randomized, Double-Blind, Crossover Comparison of Carvedilol and Metoprolol Tartrate
Condition:   Atrial FibrillationInterventions:   Drug: Carvedilol;   Drug: Metoprolol tartrateSponsor:   Creighton UniversityNot yet recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2014 Category: Research Source Type: clinical trials